Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Addex Therapeutics Ltd
  6. News
  7. Summary
    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD

(ADXN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Addex to Present at the Swiss Biotech Day

09/02/2021 | 01:00am EDT

(MORE TO FOLLOW) Dow Jones Newswires

September 02, 2021 01:00 ET (05:00 GMT)

All news about ADDEX THERAPEUTICS LTD
10/06PRESS RELEASE : Addex to Present at the Investors' Day hosted by Voxia Communication
DJ
10/06ADDEX THERAPEUTICS : to Present at the Investors' Day hosted by Voxia Communication
AQ
10/06ADDEX THERAPEUTICS : Addex to Present at the Investors' Day hosted by Voxia Communication
GL
10/06Addex to Present at the Investors' Day hosted by Voxia Communication
DJ
10/04PRESS RELEASE : Addex to Present at the 10th -2-
DJ
10/04PRESS RELEASE : Addex to Present at the 10th International Meeting on Metabotropic Glutama..
DJ
10/04Addex to Present at the 10th International Meeting on Metabotropic Glutamate Receptors
DJ
09/29ADDEX THERAPEUTICS : Type of dystonia characterized by involuntary spasms of the eyelid mu..
PU
09/29ADDEX THERAPEUTICS : Commences Mid-Stage Trial of Dipraglurant in Blepharospasm
MT
09/29ADDEX THERAPEUTICS : Starts Mid-Stage Trial For Eyelid Muscles Spasm Drug
MT
More news
Analyst Recommendations on ADDEX THERAPEUTICS LTD
More recommendations
Financials
Sales 2021 2,35 M 2,57 M 2,57 M
Net income 2021 -16,5 M -18,0 M -18,0 M
Net Debt 2021 5,28 M 5,76 M 5,76 M
P/E ratio 2021 -2,60x
Yield 2021 -
Capitalization 42,6 M 46,5 M 46,5 M
EV / Sales 2021 20,4x
EV / Sales 2022 35,6x
Nbr of Employees 27
Free-Float 65,1%
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADDEX THERAPEUTICS LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 1,25 CHF
Average target price 25,72 CHF
Spread / Average Target 1 958%
EPS Revisions
Managers and Directors
Timothy Dyer Chief Executive Officer & Director
Lénaic Teyssédou Head-Finance
Vincent M. Lawton Chairman
Roger G. Mills Director & Chief Medical Officer
Raymond George Hill Director
Sector and Competitors
1st jan.Capi. (M$)
ADDEX THERAPEUTICS LTD-37.19%46
MODERNA, INC.225.04%137 066
LONZA GROUP AG32.03%60 786
IQVIA HOLDINGS INC.42.23%48 830
SEAGEN INC.-0.71%31 638
CELLTRION, INC.-39.42%25 233